Bg pattern

METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Metoclopramide Kern Pharma 1 mg/ml Oral Solution EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What is Metoclopramide Kern Pharma and what is it used for
  2. What you need to know before you take Metoclopramide Kern Pharma
  3. How to take Metoclopramide Kern Pharma
  4. Possible side effects
  5. Storage of Metoclopramide Kern Pharma
  6. Contents of the pack and other information

1. What is Metoclopramide Kern Pharma and what is it used for

Metoclopramide Kern Pharma is an antiemetic. It contains the active substance metoclopramide. It acts on an area of the brain that prevents nausea or vomiting.

Adult population

Metoclopramide Kern Pharma is used in adults:

  • to prevent delayed nausea and vomiting that may occur after chemotherapy,
  • to prevent nausea and vomiting caused by radiotherapy,
  • to treat nausea and vomiting, including nausea and vomiting that may occur with migraine.

Metoclopramide can be taken in combination with oral painkillers in the case of migraine to make the painkillers more effective.

Pediatric population

Metoclopramide Kern Pharma is indicated in children (1-18 years of age) if other treatments do not work or cannot be used to prevent delayed nausea and vomiting that may occur after chemotherapy.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Metoclopramide Kern Pharma

Do not take Metoclopramide Kern Pharma

  • if you are allergic to metoclopramide or any of the other ingredients of this medicine (listed in section 6),
  • if you have bleeding, obstruction or perforation in the stomach or intestine,
  • if you have or may have a rare tumor of the adrenal gland, which is near the kidney

(pheochromocytoma),

  • if you have ever had involuntary muscle spasms (tardive dyskinesia) when you have been treated with a medicine,
  • if you have epilepsy,
  • if you have Parkinson's disease,
  • if you are taking levodopa (a medicine for Parkinson's disease) or dopamine agonists (see below “Using Metoclopramide Kern Pharma with other medicines”),
  • if you have ever had abnormal blood pigment levels (methemoglobinemia) or NADH cytochrome b5 reductase deficiency.

Do not give Metoclopramide Kern Pharma to children under 1 year of age (see below “Children and adolescents”).

Do not take Metoclopramide Kern Pharma if any of the above applies to you. If you are not sure, consult your doctor, pharmacist, or nurse before taking this medicine.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before taking Metoclopramide Kern Pharma if:

  • you have a history of abnormal heartbeats (prolonged QT interval) or any other heart problems
  • you have problems with the levels of salts in your blood, such as potassium, sodium, and magnesium
  • you are using other medicines known to affect the way your heart beats
  • you have any neurological problems (brain)
  • you have liver or kidney problems. The dose may need to be reduced (see section 3).

Your doctor may perform blood tests to check your blood pigment levels. In cases of abnormal levels (methemoglobinemia), treatment should be discontinued immediately and permanently.

You should wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.

Do not exceed 3 months of treatment due to the risk of involuntary muscle spasms.

Children and adolescents

Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults.

This medicine should not be used in children under 1 year of age due to the high risk of uncontrollable movements (see above “Do not take Metoclopramide Kern Pharma”).

Using Metoclopramide Kern Pharma with other medicines

Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines. This is because some medicines may affect the way metoclopramide works or metoclopramide may affect the way other medicines work. These medicines include:

  • levodopa or other medicines used to treat Parkinson's disease (see above “Do not take Metoclopramide Kern Pharma”).
  • anticholinergics (medicines used to relieve stomach spasms or cramps),
  • opioid derivatives (medicines used to treat severe pain),
  • sedatives,
  • any medicine used to treat mental health problems,
  • digoxin (a medicine used to treat heart failure),
  • cyclosporin (a medicine used to treat some problems of the immune system),
  • mivacurium and suxamethonium (medicines used to relax muscles),
  • fluoxetine and paroxetine (medicines used to treat depression).

Taking Metoclopramide Kern Pharma with food, drink, and alcohol

Do not consume alcohol during treatment with metoclopramide because it increases the sedative effect of Metoclopramide Kern Pharma.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Metoclopramide Kern Pharma may be taken during pregnancy if necessary. Your doctor will decide whether or not to administer this medicine.

Metoclopramide Kern Pharma is not recommended during breastfeeding because metoclopramide passes into breast milk and may affect your baby.

Driving and using machines

After taking Metoclopramide Kern Pharma, you may feel drowsy, dizzy, or have uncontrollable movements, such as tics, twitches, or muscle contractions, which can affect your vision and interfere with your ability to drive and use machines.

Metoclopramide Kern Pharma contains propyl parahydroxybenzoate and methyl parahydroxybenzoate

It may cause allergic reactions (possibly delayed) because it contains propyl parahydroxybenzoate (E-216) and methyl parahydroxybenzoate (E-218).

3. How to take Metoclopramide Kern Pharma

Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.

All indications (adult patients)

A single dose of 10 mg is recommended, which can be repeated up to three times a day.

The maximum recommended daily dose is 30 mg or 0.5 mg/kg body weight.

The maximum treatment duration is 5 days.

To prevent delayed nausea and vomiting that may occur after chemotherapy (children 1-18 years of age)

The recommended dose is 0.1 to 0.15 mg/kg body weight, which can be repeated up to three times a day, taken orally.

The maximum dose in 24 hours is 0.5 mg/kg body weight.

Dosing Table

Age

Body weight

Dose

Frequency

1 – 3 years

10-14 kg

1 mg (equal to 1ml)

Up to 3 times a day

3 – 5 years

15-19 kg

2 mg (equal to 2ml)

Up to 3 times a day

5 – 9 years

20-29 kg

2.5 mg (equal to 2.5 ml)

Up to 3 times a day

9 – 18 years

30-60 kg

5 mg (equal to 5 ml)

Up to 3 times a day

15 – 18 years

Over 60 kg

10 mg (equal to 10 ml)

Up to 3 times a day

Use the dosing cap included in the package of the oral solution to administer the correct dose of metoclopramide.

The dosing cap is graduated in ml. The correspondence with body weight is detailed in the dosing table.

Do not take this medicine for more than 5 days to prevent delayed nausea and vomiting that may occur after chemotherapy.

Method of administration

Metoclopramide Kern Pharma is administered orally.

You should wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.

Elderly population

The dose may need to be reduced depending on kidney problems, liver problems, and general health problems.

Adults with kidney problems

Tell your doctor if you have kidney problems. The dose should be reduced if you have moderate to severe kidney problems.

Adults with liver problems

Tell your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.

Children and adolescents

Metoclopramide should not be used in children under 1 year of age (see section 2).

If you take more Metoclopramide Kern Pharma than you should

Contact your doctor or pharmacist immediately. You may experience uncontrollable movements (extrapyramidal disorders), drowsiness, some consciousness problems, confusion, hallucinations, and heart problems. Your doctor may prescribe a treatment for these effects if necessary.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Metoclopramide Kern Pharma

Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor, nurse, or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop the treatment and inform your doctor, pharmacist, or nurse immediately if

you experience one of the following signs while taking this medicine:

  • uncontrollable movements (which often affect the head and neck). These can occur normally at the beginning of treatment and can even occur after a single administration. These movements will stop when treated properly.
  • high fever, high blood pressure, convulsions, sweating, saliva production. These can be signs of a condition called malignant neuroleptic syndrome.
  • itching and skin rash, facial swelling, lips or throat, difficulty breathing. These can be signs of an allergic reaction, which can be severe.

Very common(may affect more than 1 in 10 people)

  • feeling drowsy

Common(may affect up to 1 in 10 people)

  • depression
  • uncontrollable movements such as tics, twitches, or muscle contractions (stiffness, rigidity)
  • symptoms similar to Parkinson's disease (stiffness, tremor)
  • feeling restless
  • decreased blood pressure (particularly with intravenous administration)
  • diarrhea
  • feeling weak

Uncommon(may affect up to 1 in 100 people)

  • high levels of a hormone called prolactin in the blood, which can cause milk production in men and women who are not breastfeeding
  • irregular periods
  • hallucinations
  • decreased level of consciousness
  • slow heart rate (particularly with intravenous administration)
  • allergy
  • visual disturbances and involuntary deviation of the eyeball.

Rare(may affect up to 1 in 1,000 people)

  • confusion
  • convulsions (especially in patients with epilepsy)

Frequency not known(frequency cannot be estimated from the available data)

  • abnormal blood pigment levels: which can change the color of your skin
  • abnormal development of the breasts (gynecomastia)
  • involuntary muscle spasms after prolonged use, particularly in elderly patients
  • high fever, high blood pressure, convulsions, sweating, saliva production. These can be signs of a condition called malignant neuroleptic syndrome
  • changes in heartbeats, which can be seen on an ECG (electrocardiogram)
  • cardiac arrest (particularly with intravenous administration)
  • shock (severe drop in blood pressure) (particularly with intravenous administration)
  • fainting (particularly with intravenous administration)
  • severe allergic reaction (particularly with intravenous administration)
  • very high blood pressure.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Health Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Metoclopramide Kern Pharma

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use Metoclopramide Kern Pharma after the expiry date stated on the packaging and on the bottle. The expiry date is the last day of the month stated.

Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to a pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and other information

Composition of Metoclopramide Kern Pharma 1 mg/ml Oral Solution

  • The active substance is metoclopramide. Each ml of solution contains 1 mg of metoclopramide hydrochloride.
  • The other ingredients are: hydroxyethylcellulose, sodium saccharin, methyl parahydroxybenzoate (E-218), propyl parahydroxybenzoate (E-216), citric acid monohydrate, lemon essence, lime flavor, purified water.

Appearance of the product and packaging contents

Metoclopramide Kern Pharma is a solution packaged in a 250 ml topaz-colored plastic bottle with a 10 ml dosing cap for oral administration.

Marketing authorization holder and manufacturer

Kern Pharma, S.L.

Pol. Ind. Colón II, C/Venus 72,

08228 Terrassa (Barcelona)

Spain

Date of last revision of this leaflet: November 2019

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION

Discuss questions about METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (1175)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

0.0 (0)
Doctor

Sviatoslav Chekhun

Oncology 13 years exp.

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

5.0 (51)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
5.0 (41)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

0.0 (0)
Doctor

Bulat Garipov

General medicine 15 years exp.

Dr. Bulat Garipov is a radiologist with more than 15 years of experience, specializing in magnetic resonance imaging (MRI). Throughout his professional career, he has worked in leading diagnostic imaging centers, both in on-site practice and teleradiology, which has allowed him to develop a broad and versatile approach to radiology.

Over the years, he has gained solid experience in interpreting MRI studies in various areas, including:

  •  Neuroimaging
  •  Musculoskeletal system (MSK)
  •  Angiography
  •  Abdomen and pelvis
  •  Soft tissues

Additionally, Dr. Garipov is open to new collaboration opportunities in radiology and teleradiology projects. He offers his expertise in MRI, providing both first and second readings of studies, as well as advanced image interpretation, ensuring accurate and high-quality diagnostics.

You could consult Dr. Bulat Garipov in cases where accurate interpretation of MRI studies or a second expert opinion is required. His expertise is especially valuable in cases of suspected neurological conditions, back and joint pain, vascular disorders, as well as in the diagnosis of abdominal and pelvic diseases. The doctor also provides support in complex or unclear clinical situations, including the review of previously performed studies, which helps improve diagnostic accuracy and determine the optimal treatment strategy. A teleradiology format is available, allowing you to receive a professional opinion remotely.

5.0 (193)
Doctor

Taisiia Proida

Family medicine 7 years exp.

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Get METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION?
METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION?
The active ingredient in METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION is metoclopramide. This information helps identify medicines with the same composition but different brand names.
How much does METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION cost in pharmacies?
The average pharmacy price for METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION is around 2.5 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION?
METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION is manufactured by Kern Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION?
Other medicines with the same active substance (metoclopramide) include METOCLOPRAMIDE ACCORD 10 mg TABLETS, METOCLOPRAMIDE BASE 5 mg/mL Injectable Solution and Infusion Solution, METOCLOPRAMIDE KERN PHARMA 10mg/2ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media